Ann: Re-release of Quarterly Update & Appendix 4C, page-5

I've been watching MDR for ages and looking for signs of life. They should be doing better than they are and wonder what is wrong with their business model as a result? The small volumes and low consumer adoption of their app is extremely disappointing. @futurenow always gets upset with negative comments (sorry I missed the original announcement too) about the MDR business and model but frankly the numbers are the numbers and they are speaking for themselves. Attacking me isn't going to change what the numbers say, but it will shutdown objective discussion about the MDR business. The media says pharmacy in Australia and globally has been booming during COVID-19, so why has that not translated through to growth for MDR who have actually gone backwards? I hope you are right though and that the significant investments that have been made will translate into rapid revenue growth for sake of current holders, but it is difficult to see any evidence that would provide any hope or support for this?